Clinical trial
Nexavar Dose Evaluation Study in Patients With Advanced Renal Cell Carcinoma
NCT01557127 is registered in ClinicalTrials.gov with Bayer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Nexavar Dose Evaluation Study in Patients With Advanced Renal Cell Carcinoma
- Lead sponsor
- Bayer
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 1, 2011
- Completion date
- March 31, 2016
- Enrollment
- 205 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.